MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT

Clinical trials for MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT trials appear

Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gene therapy recipients monitored for lasting effects

Knowledge-focused ENROLLING_BY_INVITATION

This study follows 132 people with Parkinson's disease or multiple system atrophy who previously received AB-1005 gene therapy. Researchers will track safety and how well the treatment works over time. Participants are simply observed, with no new treatments given.

Matched conditions: MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT

Sponsor: AskBio Inc • Aim: Knowledge-focused

Last updated May 06, 2026 16:02 UTC

MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT

Get alerted when new MULTIPLE SYSTEM ATROPHY, PARKINSON VARIANT trials appear

Gene therapy recipients monitored for lasting effects